GSK

GSK PLC

8 superinvestors own GSK

Based on latest 13F filings — data is 45–90 days delayed

Investor	Fund	Weight	Shares	Value	Quarter	Activity
Hillman Capital Management	Hillman Value Fund	3.73%	97,432	$5.4M	2026Q1	Reduced
Dodge & Cox	Dodge & Cox	1.78%	58,662,974	$3.2B	2026Q1	Reduced
Kahn Brothers Group	Kahn Brothers Group	1.58%	160,982	$8.9M	2026Q1	Reduced
Kenneth Fisher	Fisher Asset Management	0.65%	34,522,363	$1.9B	2026Q1	Added
Tweedy Browne Co.	Tweedy Browne Value Fund	0.36%	81,785	$4.5M	2026Q1	Reduced
Sarah Ketterer	Causeway Capital Management	0.01%	11,110	$613K	2026Q1	Reduced
First Eagle Investment Management	First Eagle Investment Management	0.00%	3	$101	2023Q1	Reduced
Richard Pzena	Pzena Investment Management	0.00%	18,823	$1.0M	2026Q1	Added

Open-market purchases (P) and sales (S) from SEC Form 4 filings · last 12 months

No open-market insider trades in the last 12 months.

Form 4 filings for option exercises and other transaction types are excluded.

STOCK Act disclosures · last 12 months

Congressional trade data coming soon.

We are sourcing STOCK Act disclosures and will display them here shortly.

What Is SEC Form 4?

Understand the insider trade filings behind GSK activity.

What Is a 13F Filing?

How superinvestors disclose their quarterly holdings.

Insider Cluster Buying

Why multiple insiders buying together is a strong signal.

Superinvestor Consensus

The most widely held stocks across all tracked institutions.